Risk measures and the cost of equity in the new economy biotechnology industry

Perry Sadorsky and Irene Henriques

Global Business and Economics Review, 2003, vol. 5, issue 1, 37-55

Abstract: The cost of equity is important in valuing new investment opportunities and in evaluating the ongoing performance of existing business projects. This is especially true in the new economy biotechnology industry. The purpose of this paper is to calculate the cost of equity for the Canadian biotechnology industry using several different risk measures. The risk measures include systematic risk, total risk, downside risk, and value at risk. The results are useful for managers, budget planners, investors, policy makers, and others who are interested in the financing and risk management of new economy firms.

Keywords: risk measures; equity costs; new economy; biotechnology industry; new investment opportunities; business performance; Canada; financing; risk management. (search for similar items in EconPapers)
Date: 2003
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.inderscience.com/link.php?id=6197 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:gbusec:v:5:y:2003:i:1:p:37-55

Access Statistics for this article

More articles in Global Business and Economics Review from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().